Literature DB >> 18821747

The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Takashi Yamamoto1, Padma Nair, Neil E Jacobsen, Peg Davis, Shou-wu Ma, Edita Navratilova, Sharif Moye, Josephine Lai, Henry I Yamamura, Todd W Vanderah, Frank Porreca, Victor J Hruby.   

Abstract

To provide new insight into the determining factors of membrane-bound peptide conformation that might play an important role in peptide-receptor docking and further biological behaviors, the dodecylphosphocholine (DPC) micelle-bound conformations of bifunctional peptide derivatives of delta-preferring opioid agonists and NK1 antagonists (1: Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-O-3,5-Bzl(CF 3) 2; 2: Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-3,5-Bzl(CF 3) 2; 3: Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-Bzl) were determined based on 2D NMR studies. Although the differences in the primary sequence were limited to the C-terminus, the obtained NMR conformations were unexpectedly different for each compound. Moreover, their biological activities showed different trends in direct relation to the compound-specific conformations in DPC micelles. The important result is that not only were the NK1 antagonist activities different (the pharmacophore located at the C-terminus)but the opioid agonist activities (this pharmacophore was at the structurally preserved N-terminus) also were shifted, suggesting that a general conformational change in the bioactive state was induced due to relatively small and limited structural modifications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821747      PMCID: PMC2675940          DOI: 10.1021/jm800389v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  71 in total

1.  Folding of apocytochrome c in lipid micelles: formation of alpha-helix precedes membrane insertion.

Authors:  E A Bryson; S E Rankin; M Carey; A Watts; T J Pinheiro
Journal:  Biochemistry       Date:  1999-07-27       Impact factor: 3.162

2.  Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations.

Authors:  Manuela López de la Paz; Giacomo M S de Mori; Luis Serrano; Giorgio Colombo
Journal:  J Mol Biol       Date:  2005-04-25       Impact factor: 5.469

3.  High-resolution solution structure of the EGF-like domain of heregulin-alpha.

Authors:  N E Jacobsen; N Abadi; M X Sliwkowski; D Reilly; N J Skelton; W J Fairbrother
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

Review 4.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

5.  Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin.

Authors:  A W Lipkowski; A Misicka; P Davis; D Stropova; J Janders; M Lachwa; F Porreca; H I Yamamura; V J Hruby
Journal:  Bioorg Med Chem Lett       Date:  1999-09-20       Impact factor: 2.823

6.  Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations.

Authors:  L J Smith; K A Bolin; H Schwalbe; M W MacArthur; J M Thornton; C M Dobson
Journal:  J Mol Biol       Date:  1996-01-26       Impact factor: 5.469

7.  Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers.

Authors:  Muthu Dhanasekaran; Michael M Palian; Isabel Alves; Larisa Yeomans; Charles M Keyari; Peg Davis; Edward J Bilsky; Richard D Egleton; Henry I Yamamura; Neil E Jacobsen; Gordon Tollin; Victor J Hruby; Frank Porreca; Robin Polt
Journal:  J Am Chem Soc       Date:  2005-04-20       Impact factor: 15.419

8.  Conformational study of [Met5]enkephalin-Arg-Phe in the presence of phosphatidylserine vesicles.

Authors:  M D'Alagni; M Delfini; A Di Nola; M Eisenberg; M Paci; L G Roda; G Veglia
Journal:  Eur J Biochem       Date:  1996-09-15

9.  The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: presence of a disulfide bond.

Authors:  N D Boyd; R Kage; J J Dumas; J E Krause; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  18 in total

1.  Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.

Authors:  Takashi Yamamoto; Padma Nair; Neil E Jacobsen; Vinod Kulkarni; Peg Davis; Shou-Wu Ma; Edita Navratilova; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

2.  Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila I Keresztes; Takashi Yamamoto; Todd W Vanderah; William R Roeske; Victor J Hruby; Eva V Varga
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

3.  Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.

Authors:  Srinivas Deekonda; David Rankin; Peg Davis; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-08-14       Impact factor: 2.823

4.  Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.

Authors:  Steven Ballet; Debby Feytens; Koen Buysse; Nga N Chung; Carole Lemieux; Suneeta Tumati; Attila Keresztes; Joost Van Duppen; Josephine Lai; Eva Varga; Frank Porreca; Peter W Schiller; Jozef Vanden Broeck; Dirk Tourwé
Journal:  J Med Chem       Date:  2011-03-17       Impact factor: 7.446

5.  Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.

Authors:  Takashi Yamamoto; Padma Nair; Tally M Largent-Milnes; Neil E Jacobsen; Peg Davis; Shou-Wu Ma; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

6.  Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.

Authors:  Paolo Grieco; Diego Brancaccio; Ettore Novellino; Victor J Hruby; Alfonso Carotenuto
Journal:  Eur J Med Chem       Date:  2011-05-23       Impact factor: 6.514

Review 7.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

8.  Novel cyclic biphalin analogue with improved antinociceptive properties.

Authors:  Adriano Mollica; Alfonso Carotenuto; Ettore Novellino; Antonio Limatola; Roberto Costante; Francesco Pinnen; Azzurra Stefanucci; Stefano Pieretti; Anna Borsodi; Reza Samavati; Ferenc Zador; Sándor Benyhe; Peg Davis; Frank Porreca; Victor J Hruby
Journal:  ACS Med Chem Lett       Date:  2014-07-14       Impact factor: 4.345

Review 9.  Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.

Authors:  Aswini Kumar Giri; Victor J Hruby
Journal:  Expert Opin Investig Drugs       Date:  2013-12-13       Impact factor: 6.206

Review 10.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.